Roche’s chronic cough program has sputtered to a halt. The drugmaker, which axed the program after the drug candidate ...

Eastern Bank increased its position in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) by 285.6% during the 3rd quarter, ...

Roche CEO Urges FTC to Block Novo Nordisks Acquisition of Catalent Roches CEO, Thomas Schinecker, has called on authorities ...

The CEO of pharmaceuticals giant Roche has urged authorities to block the takeover of contract drug manufacturer Catalent by ...

Wells Fargo lowered the firm’s price target on Regeneron (REGN) to $1,050 from $1,200 and keeps an Overweight rating on the shares. Given ...

Recent health news includes Amgen's launch of an Eylea biosimilar in the U.S., Slovakia's bird flu outbreak, and China's ...

The best performers of the session on the Dow Jones Industrial Average were Microsoft Corporation (NASDAQ: MSFT ), which rose ...

SAN DIEGO, Oct. 22, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: ARTV), a clinical-stage biotechnology company whose mission is to ...

Amgen will launch its biosimilar version of Regeneron's blockbuster eye care drug Eylea following a U.S. appeals court ruling ...

Amgen will launch its biosimilar version of Regeneron's blockbuster eye care drug Eylea following a U.S. appeals court ruling ...

Regeneron spent $5 billion repurchasing shares from Sanofi in May 2020 and $900 million repurchasing global rights to Libtayo in July 2022, yet a windfall from sales of its Covid antibody cocktail as ...

A Maryland drug affordability board can move forward with a plan to cap how much the state and local governments pay for ...